Biotech · Private company
NeuroEM Therapeutics, Inc.
Track this companyFree. Adds NeuroEM Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MemorEMPhase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MemorEMAlzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MemorEM 1000Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM DeviceNA · ENROLLING_BY_INVITATION · started Dec 1, 2025ClinicalTrials.gov NCT07222605 · fetched Nov 12, 2026
- Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological DiseasesNA · ENROLLING_BY_INVITATION · started Jul 31, 2025ClinicalTrials.gov NCT07049341 · fetched Nov 12, 2026
- Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's DiseasePHASE1_PHASE2 · UNKNOWN · started Feb 10, 2020ClinicalTrials.gov NCT04271163 · fetched Nov 12, 2026
- Transcranial Electromagnetic Treatment Against Alzheimer's DiseaseNA · COMPLETED · started Apr 15, 2019ClinicalTrials.gov NCT03927040 · fetched Nov 12, 2026
- Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's DiseaseNA · COMPLETED · started Oct 1, 2017ClinicalTrials.gov NCT02958930 · fetched Nov 12, 2026